Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amgen cholesterol drug meets goal of third late stage trial
Yahoo/Reuters
Thursday, January 23, 2014 - 5:53pm
tags:
Amgen, evolocumab, PCSK9 inhibitors
[video] Sanofi Has One of Top 5 Drug Pipelines, CEO Says
Bloomberg
Thursday, January 23, 2014 - 5:52pm
tags:
Sanofi, Pharma CEOs, Chris Viehbacher
Bristol-Myers' New Nivolumab Trial Sparks Worries
Investors.com
Thursday, January 23, 2014 - 5:50pm
tags:
Bristol-Myers Squibb, nivolumab, clinical trials, non-small cell lung cancer
Medtronic's SureScan Wins FDA Approval
Yahoo/Reuters
Thursday, January 23, 2014 - 5:47pm
tags:
SureScan, Medtronic, FDA, devices
FDA halts drug imports from Ranbaxy plant in India
Yahoo/AP
Thursday, January 23, 2014 - 5:42pm
tags:
FDA, Ranbaxy, India
Ariad Joins Rumor Mill: Hope May Trump Reality
Wall St 24/7
Thursday, January 23, 2014 - 11:06am
tags:
Ariad Pharmaceuticals, Eli Lilly, M&A
Plandaí Sits at the Head of the Medical Marijuana Class
Yahoo/Accesswire
Thursday, January 23, 2014 - 10:46am
tags:
marijuana, Plandai Biotechnology
There’s A Patent Cliff But AstraZeneca Has A Jetpack
Motley Fool
Thursday, January 23, 2014 - 10:43am
tags:
patents, patent cliff, AstraZeneca, Crestor, Symbicort
St. Jude To Acquire Heart Failure Startup CardioMEMS before Mid 2014
Medical Device and Diagnostic Industry
Thursday, January 23, 2014 - 10:00am
tags:
St. Jude Medical, M&A, CardioMEMS, diagnostics, devices
The State of Gene Therapy in a Biogen Idec World: Sangamo, Bluebird and Acceleron
TheStreet.com
Thursday, January 23, 2014 - 9:53am
tags:
gene therapy, Biogen Idec, Sangamo BioSciences, Bluebird Bio, Acceleron
What You Need to Know About Amgen's Oncology Line-Up
Motley Fool
Thursday, January 23, 2014 - 9:52am
tags:
Amgen, oncology, T-Vec, Kyprolis
Inovio announces new immune activator
Yahoo/Fly on the Wall
Thursday, January 23, 2014 - 9:50am
tags:
Inovio, IL-33, immune activators, DNA vaccines
Advaxis And Inovio Race For First Cervical Cancer Immunotherapy
Seeking Alpha
Thursday, January 23, 2014 - 9:48am
tags:
Advaxis, Inovio, cervical cancer, immunotherapy, ADXS-HPV, VGX-3100
What To Know About Questcor Pharmaceuticals' Most Important Drug
Motley Fool
Thursday, January 23, 2014 - 9:37am
tags:
Questcor Pharmaceuticals, Acthar, multiple sclerosis, kidney disease, rheumatology
Johnson & Johnson Now #6 Largest Company, Surpassing General Electric
TheStreet.com
Thursday, January 23, 2014 - 9:35am
tags:
JNJ
Genextra Holds on After $1.2 Billion Intercept Windfall
Bloomberg
Thursday, January 23, 2014 - 9:35am
tags:
Genextra, Intercept Pharma
What to Look for When Pfizer Inc. Reports Earnings
Motley Fool
Thursday, January 23, 2014 - 8:25am
tags:
Pfizer, earnings
High Stakes Intrigue In Hep C: Bristol-Myers Vs. Gilead
Seeking Alpha
Thursday, January 23, 2014 - 8:23am
tags:
hepatitis C, Gilead Sciences, Bristol-Myers Squibb, Sovaldi, declatasvir
Slowing Sales for Johnson & Johnson's Zytiga May Be Good News for Medivation
Motley Fool
Thursday, January 23, 2014 - 8:22am
tags:
JNJ, Zytiga, Medivation, Xtandi, prostate cancer
Drugmaker Merck Tries To Jump-Start Slow Growth
Investors.com
Thursday, January 23, 2014 - 8:20am
tags:
Merck, Roger Perlmutter, R&D

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.